UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium

Estevao, C; Bowers, CE; Luo, D; Sarker, M; Hoeh, AE; Frudd, K; Turowski, P; (2021) CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium. Brain, Behavior, & Immunity - Health , 18 , Article 100370. 10.1016/j.bbih.2021.100370. (In press). Green open access

[thumbnail of Frudd_CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium_VoR.pdf]
Preview
Text
Frudd_CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium_VoR.pdf - Published Version

Download (3MB) | Preview

Abstract

Background: During neuroinflammation many chemokines alter the function of the blood-brain barrier (BBB) that regulates the entry of macromolecules and immune cells into the brain. As the milieu of the brain is altered, biochemical and structural changes contribute to the pathogenesis of neuroinflammation and may impact on neurogenesis. The chemokine CCL4, previously known as MIP-1β, is upregulated in a wide variety of central nervous system disorders, including multiple sclerosis, where it is thought to play a key role in the neuroinflammatory process. However, the effect of CCL4 on BBB endothelial cells (ECs) is unknown. Materials and methods: Expression and distribution of CCR5, phosphorylated p38, F-actin, zonula occludens-1 (ZO-1) and vascular endothelial cadherin (VE-cadherin) were analysed in the human BBB EC line hCMEC/D3 by Western blot and/or immunofluorescence in the presence and absence of CCL4. Barrier modulation in response to CCL4 using hCMEC/D3 monolayers was assessed by measuring molecular flux of 70 ​kDa RITC-dextran and transendothelial lymphocyte migration. Permeability changes in response to CCL4 in vivo were measured by an occlusion technique in pial microvessels of Wistar rats and by fluorescein angiography in mouse retinae. Results: CCR5, the receptor for CCL4, was expressed in hCMEC/D3 cells. CCL4 stimulation led to phosphorylation of p38 and the formation of actin stress fibres, both indicative of intracellular chemokine signalling. The distribution of junctional proteins was also altered in response to CCL4: junctional ZO-1 was reduced by circa 60% within 60 ​min. In addition, surface VE-cadherin was redistributed through internalisation. Consistent with these changes, CCL4 induced hyperpermeability in vitro and in vivo and increased transmigration of lymphocytes across monolayers of hCMEC/D3 cells. Conclusion: These results show that CCL4 can modify BBB function and may contribute to disease pathogenesis.

Type: Article
Title: CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.bbih.2021.100370
Publisher version: https://doi.org/10.1016/j.bbih.2021.100370
Language: English
Additional information: © 2021 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Permeability, Chemokines, CCL4, Inflammation, Neuroinflammation, Neurogenesis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
URI: https://discovery.ucl.ac.uk/id/eprint/10137654
Downloads since deposit
26Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item